Screener
Travere Therapeutics, Inc. TVTX Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
FAQ
- What is Travere Therapeutics, Inc.'s net debt?
- Travere Therapeutics, Inc. (TVTX) reported net debt of -$62.78M in Q1 2026.
- How has Travere Therapeutics, Inc.'s net debt changed year-over-year?
- Travere Therapeutics, Inc.'s net debt decreased by 325.0% year-over-year, from $27.9M to -$62.78M.
- What is the long-term trend for Travere Therapeutics, Inc.'s net debt?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s net debt has grown at a 8.6% compound annual growth rate (CAGR), from -$50.27M to -$76.03M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Travere Therapeutics, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude